Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer

Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.

doi:10.1158/0008-5472.can-17-0976

Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer

Date

2017

Authors

Ponnusamy, S.

Coss, C.

Thiyagarajan, T.

Watts, K.

Hwang, D.-J.

He, Y.

Selth, L.

McEwan, I.

Duke, C.

Pagadala, J.

Type:

Journal article

Citation

Cancer Research, 2017; 77(22):6282-6298

Statement of Responsibility

Suriyan Ponnusamy, Christopher C. Coss, Thirumagal Thiyagarajan, Kate Watts, Dong-Jin Hwang, Yali He, Luke A. Selth, Iain J. McEwan, Charles B. Duke, Jayaprakash Pagadala, Geetika Singh, Robert W. Wake, Christopher Ledbetter, Wayne D. Tilley, Tudor Moldoveanu, James T. Dalton, Duane D. Miller and Ramesh Narayanan

DOI

10.1158/0008-5472.can-17-0976

Abstract

Abstract not available

Rights

Published Version

https://doi.org/10.1158/0008-5472.can-17-0976

Persistent link to this record

http://hdl.handle.net/2440/119732

Full item page

Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record